Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyHematologic NeoplasmsProtocol groupPlasma cell neoplasmsTransplantationDiseaseMultiple MyelomaStem Cell Transplantation, AutologousSubgroupICD10C90.-C90.0-Z94.80MeSHPlasmacytomaTransplantation, AutologousSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronMelphalanValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronMelphalanValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronMelphalanValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronMelphalanValaciclovirNo. Substances8Protocol classificationTherapy classificationcurrent standardIntensityHochdosis, myeloablativ, bei autologer SZTTherapy indicationFirst lineTherapy phaseautologous stem cell transplantationTherapy intentioncurativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorAttal MDiseaseAuto-SZT beim MMOriginInstitut Universitaire du Cancer de Toulouse-Oncopole and Service d'Epidemiologie, Centre Hospitalier et Universitaire de Toulouse, Toulouse, FranceProtokolle in Überarbeitung 1 protocol foundRevision: Melphalan 100, multiples Myelom, autologe Stammzelltransplantation (PID528 V2.3)
